MET Immunohistochemistry Should Be Avoided in Selecting Non–small-cell Lung Cancers Requiring MET Exon 14 Skipping Mutation Analysis - Université de Bretagne Occidentale Access content directly
Journal Articles Clinical Lung Cancer Year : 2019

MET Immunohistochemistry Should Be Avoided in Selecting Non–small-cell Lung Cancers Requiring MET Exon 14 Skipping Mutation Analysis

No file

Dates and versions

hal-02262486 , version 1 (02-08-2019)

Identifiers

Cite

Laetitia Lambros, Arnaud Uguen. MET Immunohistochemistry Should Be Avoided in Selecting Non–small-cell Lung Cancers Requiring MET Exon 14 Skipping Mutation Analysis. Clinical Lung Cancer, 2019, 20 (3), pp.e418-e420. ⟨10.1016/j.cllc.2018.12.002⟩. ⟨hal-02262486⟩
48 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More